Regression of Coronary Fatty Plaque and Risk of Cardiac Events According to Blood Pressure Status: Data From a Randomized Trial of Eicosapentaenoic Acid and Docosahexaenoic Acid in Patients With Coronary Artery Disease.

J Am Heart Assoc · 2023 · PMC10547278 · PMID 37681568

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

approached significanceP =0.064so close (0.05 < p ≤ 0.1)

When examined by neutrophil/lymphocyte ratio (NLR), Table 9 reports that normotensive patients taking EPA+DHA had a significant reduction in NLR (2.64±0.87 at baseline vs 2.39±1.03 at 30‐month follow‐up, P =0.024), whereas normotensive patients taking control had an increase that approached significance: 2.09±0.85 at baseline versus 2.47±0.96 at 30‐month follow‐up ( P =0.064).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.